Cargando…
Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer
This study evaluated the 5-year clinical outcomes of the Genoss DES, the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer. We previously conducted the first-in-patient prospective, multicenter, randomized trial with a 1:1 ratio of patients using the Genoss DES...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133141/ https://www.ncbi.nlm.nih.gov/pubmed/34106607 http://dx.doi.org/10.1097/MD.0000000000025765 |
_version_ | 1783695025391009792 |
---|---|
author | Seo, Kyoung-Woo Yang, Hyoung-Mo Yoon, Junghan Kim, Hyo-Soo Chang, Kiyuk Lim, Hong-Seok Choi, Byoung-Joo Choi, So-Yeon Yoon, Myeong-Ho Lee, Seung-Hwan Ahn, Sung Gyun Youn, Young Jin Lee, Jun-Won Koo, Bon-Kwon Park, Kyung Woo Yang, Han-Mo Han, Jung-Kyu Chung, Wook-Sung Park, Hun-Jun Hwang, Byung-Hee Choo, Eun-Ho Oh, Gyu-Chul Tahk, Seung-Jea |
author_facet | Seo, Kyoung-Woo Yang, Hyoung-Mo Yoon, Junghan Kim, Hyo-Soo Chang, Kiyuk Lim, Hong-Seok Choi, Byoung-Joo Choi, So-Yeon Yoon, Myeong-Ho Lee, Seung-Hwan Ahn, Sung Gyun Youn, Young Jin Lee, Jun-Won Koo, Bon-Kwon Park, Kyung Woo Yang, Han-Mo Han, Jung-Kyu Chung, Wook-Sung Park, Hun-Jun Hwang, Byung-Hee Choo, Eun-Ho Oh, Gyu-Chul Tahk, Seung-Jea |
author_sort | Seo, Kyoung-Woo |
collection | PubMed |
description | This study evaluated the 5-year clinical outcomes of the Genoss DES, the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer. We previously conducted the first-in-patient prospective, multicenter, randomized trial with a 1:1 ratio of patients using the Genoss DES and Promus Element stents; the angiographic and clinical outcomes of the Genoss DES stent were comparable to those of the Promus Element stent. The primary endpoint was major adverse cardiac events (MACE), which was a composite of death, myocardial infarction (MI), and target lesion revascularization (TLR) at 5 years. We enrolled 38 patients in the Genoss DES group and 39 in the Promus Element group. Thirty-eight patients (100%) from the Genoss DES group and 38 (97.4%) from the Promus Element group were followed up at 5 years. The rates of MACE (5.3% vs 12.8%, P = .431), death (5.3% vs 10.3%, P = .675), TLR (2.6% vs 2.6%, P = 1.000), and target vessel revascularization (TVR) (7.9% vs 2.6%, P = .358) at 5 years did not differ significantly between the groups. No TLR or target vessel revascularization was reported from years 1 to 5 after the index procedure, and no MI or stent thrombosis occurred in either group during 5 years. The biodegradable polymer Genoss DES and durable polymer Promus Element stents showed comparable low rates of MACE at the 5-year clinical follow-up. |
format | Online Article Text |
id | pubmed-8133141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-81331412021-05-24 Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer Seo, Kyoung-Woo Yang, Hyoung-Mo Yoon, Junghan Kim, Hyo-Soo Chang, Kiyuk Lim, Hong-Seok Choi, Byoung-Joo Choi, So-Yeon Yoon, Myeong-Ho Lee, Seung-Hwan Ahn, Sung Gyun Youn, Young Jin Lee, Jun-Won Koo, Bon-Kwon Park, Kyung Woo Yang, Han-Mo Han, Jung-Kyu Chung, Wook-Sung Park, Hun-Jun Hwang, Byung-Hee Choo, Eun-Ho Oh, Gyu-Chul Tahk, Seung-Jea Medicine (Baltimore) 3400 This study evaluated the 5-year clinical outcomes of the Genoss DES, the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer. We previously conducted the first-in-patient prospective, multicenter, randomized trial with a 1:1 ratio of patients using the Genoss DES and Promus Element stents; the angiographic and clinical outcomes of the Genoss DES stent were comparable to those of the Promus Element stent. The primary endpoint was major adverse cardiac events (MACE), which was a composite of death, myocardial infarction (MI), and target lesion revascularization (TLR) at 5 years. We enrolled 38 patients in the Genoss DES group and 39 in the Promus Element group. Thirty-eight patients (100%) from the Genoss DES group and 38 (97.4%) from the Promus Element group were followed up at 5 years. The rates of MACE (5.3% vs 12.8%, P = .431), death (5.3% vs 10.3%, P = .675), TLR (2.6% vs 2.6%, P = 1.000), and target vessel revascularization (TVR) (7.9% vs 2.6%, P = .358) at 5 years did not differ significantly between the groups. No TLR or target vessel revascularization was reported from years 1 to 5 after the index procedure, and no MI or stent thrombosis occurred in either group during 5 years. The biodegradable polymer Genoss DES and durable polymer Promus Element stents showed comparable low rates of MACE at the 5-year clinical follow-up. Lippincott Williams & Wilkins 2021-05-14 /pmc/articles/PMC8133141/ /pubmed/34106607 http://dx.doi.org/10.1097/MD.0000000000025765 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | 3400 Seo, Kyoung-Woo Yang, Hyoung-Mo Yoon, Junghan Kim, Hyo-Soo Chang, Kiyuk Lim, Hong-Seok Choi, Byoung-Joo Choi, So-Yeon Yoon, Myeong-Ho Lee, Seung-Hwan Ahn, Sung Gyun Youn, Young Jin Lee, Jun-Won Koo, Bon-Kwon Park, Kyung Woo Yang, Han-Mo Han, Jung-Kyu Chung, Wook-Sung Park, Hun-Jun Hwang, Byung-Hee Choo, Eun-Ho Oh, Gyu-Chul Tahk, Seung-Jea Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer |
title | Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer |
title_full | Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer |
title_fullStr | Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer |
title_full_unstemmed | Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer |
title_short | Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer |
title_sort | five-year clinical outcomes of the first korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer |
topic | 3400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133141/ https://www.ncbi.nlm.nih.gov/pubmed/34106607 http://dx.doi.org/10.1097/MD.0000000000025765 |
work_keys_str_mv | AT seokyoungwoo fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT yanghyoungmo fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT yoonjunghan fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT kimhyosoo fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT changkiyuk fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT limhongseok fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT choibyoungjoo fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT choisoyeon fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT yoonmyeongho fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT leeseunghwan fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT ahnsunggyun fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT younyoungjin fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT leejunwon fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT koobonkwon fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT parkkyungwoo fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT yanghanmo fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT hanjungkyu fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT chungwooksung fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT parkhunjun fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT hwangbyunghee fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT chooeunho fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT ohgyuchul fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer AT tahkseungjea fiveyearclinicaloutcomesofthefirstkoreanmadesirolimuselutingcoronarystentwithabluminalbiodegradablepolymer |